Evidence map›Paper›PMID 38282330›Full record

ArticleYeast (Chichester, England)2024

An ultra high-throughput, massively multiplexable, single-cell RNA-seq platform in yeasts.

Leandra Brettner, Rachel Eder, Kara Schmidlin, Kerry Geiler-Samerotte

Abstract read
In one paragraph

Article in Yeast (Chichester, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Leandra BrettnerBiodesign Institute Center for Mechanisms of Evolution, Arizona State University, Tempe, Arizona, USA.
Rachel EderBiodesign Institute Center for Mechanisms of Evolution, Arizona State University, Tempe, Arizona, USA.
Kara SchmidlinBiodesign Institute Center for Mechanisms of Evolution, Arizona State University, Tempe, Arizona, USA.
Kerry Geiler-SamerotteBiodesign Institute Center for Mechanisms of Evolution, Arizona State University, Tempe, Arizona, USA.

Funding

A quantitative examination of cellular mechanisms that modulate the impacts of genetic variation - Renewal - 1R35GM133674 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI Kerry A Geiler-Samerotte · 2019 to 2026
$2.8M
NIGMS NIH HHS R35 GM133674NIH HHS R35GM133674
6 · The paper itself

Abstract

Yeasts are naturally diverse, genetically tractable, and easy to grow such that researchers can investigate any number of genotypes, environments, or interactions thereof. However, studies of yeast transcriptomes have been limited by the processing capabilities of traditional RNA sequencing techniques. Here we optimize a powerful, high-throughput single-cell RNA sequencing (scRNAseq) platform, SPLiT-seq (Split Pool Ligation-based Transcriptome sequencing), for yeasts and apply it to 43,388 cells of multiple species and ploidies. This platform utilizes a combinatorial barcoding strategy to enable massively parallel RNA sequencing of hundreds of yeast genotypes or growth conditions at once. This method can be applied to most species or strains of yeast for a fraction of the cost of traditional scRNAseq approaches. Thus, our technology permits researchers to leverage "the awesome power of yeast" by allowing us to survey the transcriptome of hundreds of strains and environments in a short period of time and with no specialized equipment. The key to this method is that sequential barcodes are probabilistically appended to cDNA copies of RNA while the molecules remain trapped inside of each cell. Thus, the transcriptome of each cell is labeled with a unique combination of barcodes. Since SPLiT-seq uses the cell membrane as a container for this reaction, many cells can be processed together without the need to physically isolate them from one another in separate wells or droplets. Further, the first barcode in the sequence can be chosen intentionally to identify samples from different environments or genetic backgrounds, enabling multiplexing of hundreds of unique perturbations in a single experiment. In addition to greater multiplexing capabilities, our method also facilitates a deeper investigation of biological heterogeneity, given its single-cell nature. For example, in the data presented here, we detect transcriptionally distinct cell states related to cell cycle, ploidy, metabolic strategies, and so forth, all within clonal yeast populations grown in the same environment. Hence, our technology has two obvious and impactful applications for yeast research: the first is the general study of transcriptional phenotypes across many strains and environments, and the second is investigating cell-to-cell heterogeneity across the entire transcriptome.

Indexed as

Gene Expression ProfilingSingle-Cell Gene Expression AnalysisHigh-Throughput Nucleotide SequencingSaccharomyces cerevisiaeTranscriptomeCandida albicanshigh‐throughputlow‐costSaccharomyces cerevisiaesingle‐cell RNA sequencingyeast

Identifiers

PMID38282330
PMCPMC11146634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.